AAIPharma Services Announces Executive Appointments
Published: Sep 28, 2010
“Tim and Rob bring to AAIPharma Services a wealth of pharmaceutical and biotechnology experience,” said Mr. Walsh. “Tim’s background in marketing and leading high-growth business teams combined with Rob’s focus on business development and customer service will add immense value to our efforts to expand our services and offer greater value to our customers in the future,” said Mr. Walsh.
Mr. Martin has more than 25 years of sales and marketing leadership experience in both product and service offerings in the pharmaceutical and biotechnology sectors. Most recently, he was president and CEO of Express, a specialty provider of logistics services to hospitals, laboratories and ancillary service businesses in healthcare. He also served in executive roles with several Fortune 500 healthcare companies including as senior vice president and general manager of Cardinal Health’s Specialty Pharmaceutical Services division.
Rob Goshert brings 30 years of leadership experience in business development, sales and marketing, business operations and corporate accounts. His experience spans proprietary pharmaceuticals, critical care generics, parenteral contract manufacturing, bio-assay diagnostics, and pharmaceutical development services in previous executive roles at LyphoMed, Fujisawa USA and Gensia Sicor.
About AAIPharma Services Corp.
AAIPharma Services Corp. is a leading provider of services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. It is headquartered in Wilmington, North Carolina. For more information on the company, visit www.aaipharma.com.